About us

OCON Healthcare develops, manufactures and commercialises innovative women’s health products based on IUB™, its proprietary intrauterine platform. The platform, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and intrauterine drugs.

OCON’s first product, IUB™ Ballerine®, is a copper-based hormone-free intrauterine contraceptive. The IUB™ Ballerine® is CE approved and available in 21 countries across Europe, South Africa and Israel.

The Company is also developing a strong pipeline of products using the IUB™ frame for hormonal contraception and additional indications including abnormal uterine bleeding and infertility.

OCON’s shareholders include:

  • Insud Pharma
  • Pontifax
  • Docor
  • RUSNANO

OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks. The private Company, established in 2011, is headquartered in Modiin, Israel.

 


Our Mission - to introduce innovative high quality intrauterine technology that improves women's health and quality of life.

IUB, OCON and the OCON and IUB logos are trademarks of OCON Medical Ltd.
Ballerine and Sphera are registered trademarks of OCON Medical Ltd.
OCON products are not yet approved for sale in the United States. IUB Ballerine MAXI: CE mark pending. Copyright OCON Medical Ltd., d/b/a OCON Healthcare.